He et al. showed that targeted disruption of PPARγ in adipose tissue of HFD mice induced hyperlipidemia, liver steatosis, and reduction of circulating leptin and ACRP30, however, these mice gained less body weight and was accompanied with increased hepatic IR [81]. Here, ADIPOQ is linked to fatty liver disease.